Syndrome of inappropriate antidiuretic hormone — euvolemic hyponatremia from non-osmotic AVP release.
Also known as: SIADH, syndrome of inappropriate ADH, inappropriate antidiuresis, euvolemic hyponatremia
Overview
Hypotonic hyponatremia due to non-physiologic (non-osmotic, non-volume-driven) secretion of antidiuretic hormone, producing concentrated urine in the face of dilute serum. Patient is clinically euvolemic and has normal renal, adrenal, and thyroid function.
Epidemiology
One of the most common causes of hyponatremia in hospitalized patients. Underlying causes vary by age — malignancy and CNS disease in adults; infections and medications across all ages.
Try two board-style SIADH questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1EndocrineMedium
A 70-year-old man with small cell lung cancer has confusion and seizures. Sodium is 116 mEq/L, serum osmolality is low, urine osmolality is high, and urine sodium is elevated. Which of the following is the most appropriate initial treatment?
AOral tolvaptan at 15 mg daily
BHypertonic saline given as a bolus
CFluid restriction to 800 mL daily
DIsotonic saline at 100 mL per hour
EOral demeclocycline started now
Reveal answer & full explanation
Correct answer: B — Hypertonic saline given as a bolus
AOral tolvaptan at 15 mg daily
BHypertonic saline given as a bolus✓
CFluid restriction to 800 mL daily
DIsotonic saline at 100 mL per hour
EOral demeclocycline started now
Why Hypertonic saline given as a bolus is correct
Hyponatremia with seizures is a neurologic emergency, and 3% hypertonic saline is the only therapy that raises serum sodium fast enough to reverse cerebral edema and stop the seizing.
The pattern (euvolemic, low serum osmolality, inappropriately concentrated urine, urine sodium elevated) is SIADH, here from ectopic ADH by small cell lung cancer.
Guidelines target a small rapid bolus to lift sodium 4-6 mEq/L acutely, then strict limits to avoid overcorrection.
Why the others are wrong
Isotonic saline at 100 mL per hour — Right-test-wrong-patient trap: in SIADH the high urine osmolality can exceed that of normal saline, so the free water is retained and sodium can paradoxically fall.
Fluid restriction to 800 mL daily — Restriction is the mainstay of chronic or minimally symptomatic SIADH, but it lifts sodium only about 1-2 mEq/L per day and does nothing for the cerebral edema driving the seizures.
Oral demeclocycline started now — Right-drug-wrong-tempo trap: demeclocycline takes days to act and treats chronic SIADH, not a patient who is actively seizing.
Oral tolvaptan at 15 mg daily — newer-drug trap: tolvaptan blocks the V2 receptor and does raise sodium in SIADH, but it is not for patients who need sodium raised urgently to treat serious neurologic symptoms, because its effect is less controllable than a hypertonic bolus and it can overcorrect.
Question 2EndocrineMedium
A euvolemic 70-year-old man with small cell lung cancer has sodium 122 mEq/L, low serum osmolality, high urine osmolality, and high urine sodium. Which of the following is the most appropriate initial treatment if symptoms are mild?
AIntravenous isotonic saline bolus
BOral free-water restriction
COral tolvaptan 15 mg daily
DOral fludrocortisone 0.1 mg daily
EIntravenous 3% hypertonic saline
Reveal answer & full explanation
Correct answer: B — Oral free-water restriction
AIntravenous isotonic saline bolus
BOral free-water restriction✓
COral tolvaptan 15 mg daily
DOral fludrocortisone 0.1 mg daily
EIntravenous 3% hypertonic saline
Why Oral free-water restriction is correct
Euvolemic hypotonic hyponatremia with concentrated urine and high urine sodium in lung cancer is SIADH.
Free-water restriction is first-line for mild or chronic SIADH because the core problem is water excess.
It corrects sodium slowly and avoids overcorrection in an asymptomatic or mildly symptomatic patient.
Why the others are wrong
Intravenous 3% hypertonic saline — Hypertonic saline is reserved for severe symptomatic hyponatremia with seizures or coma; using it for mild symptoms risks osmotic demyelination (right-drug-wrong-severity trap).
Intravenous isotonic saline bolus — In SIADH the kidney excretes the sodium and retains the water, so isotonic saline can paradoxically lower serum sodium further (fluid-reflex trap).
Oral tolvaptan 15 mg daily — Vaptans are a later option for persistent SIADH, not the initial mild-case step, and carry overcorrection and hepatotoxicity risk (escalation-too-early trap).
Oral fludrocortisone 0.1 mg daily — the high urine sodium can suggest cerebral or renal salt wasting, where fludrocortisone helps restore sodium and volume, but salt-wasting states are hypovolemic, whereas this euvolemic patient with small cell lung cancer has ADH-driven water excess, and a mineralocorticoid adds hypokalemia and hypertension risk (salt-wasting-vs-SIADH trap).
That's 2. Get 7,700+ more.
Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.
You've read your 2 free diagnosis previews. Create your free account to unlock the full SIADH outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Surgery (postoperative period, especially pituitary surgery)
HIV/AIDS, severe pain, nausea, prolonged exercise (marathon hyponatremia)
Pathophysiology
AVP is secreted despite normal or low plasma osmolality. ADH binds V2 receptors in collecting ducts, inserting aquaporin-2 channels and increasing water reabsorption. Free water retention dilutes plasma sodium. Volume expansion suppresses renin-angiotensin-aldosterone, increases ANP, and causes natriuresis — patient remains euvolemic, not edematous.
Clinical presentation
Symptoms
Mild (Na 130-135): often asymptomatic, headache, lethargy, anorexia, nausea
Moderate (Na 120-130): confusion, gait instability, fatigue, falls
Severe (Na <120 or rapid drop): seizure, coma, respiratory arrest, brain herniation
Chronic mild hyponatremia: subtle gait disturbance, falls, fractures, osteoporosis
Signs / physical exam
Euvolemic — no edema, no JVD, no orthostasis, moist mucous membranes
Altered mental status proportional to severity and rate of fall
Seizure activity, focal neurologic signs (severe)
Classic findings
Hyponatremic patient with concentrated urine (osm >100, often >300), high urine sodium, euvolemic clinical exam, and a known SIADH-inducing cause.
Differential diagnosis
Hypovolemic hyponatremia — Volume depletion from diuretics, GI losses, third spacing; orthostatic, dry mucous membranes; urine Na <20 (extrarenal) or >20 (renal)
Adrenal insufficiency — Hypovolemia, hyperkalemia, hyperpigmentation; cosyntropin stim test
Hypothyroidism (severe) — TSH elevated; rarely the sole cause of hyponatremia unless myxedema
Primary polydipsia — Excess water intake; dilute urine appropriately; total water intake >10 L/day
Beer potomania / tea-and-toast diet — Low solute intake limits water excretion; serum osm low; dilute urine; diet history
Cerebral salt wasting — Hypovolemic hyponatremia in CNS injury; treat with NORMAL SALINE (opposite of SIADH); high urine Na
Reset osmostat — Mild chronic hyponatremia, otherwise asymptomatic; pregnancy or chronic illness; normal handling of acute water load
Pseudohyponatremia (hyperlipidemia, hyperproteinemia) — Sodium measured low on flame photometry but actually normal; check direct ion-selective electrode
Hypertonic hyponatremia (hyperglycemia, mannitol) — Osmotically active solute draws water into vascular space; correct Na for glucose (1.6 mEq Na per 100 mg/dL glucose above 100)
Diagnostic workup
Diagnostic criteria
Schwartz-Bartter criteria: (1) hypotonic hyponatremia, (2) inappropriately concentrated urine (urine osm > serum osm), (3) clinical euvolemia, (4) urine Na elevated (>30-40), (5) normal thyroid, adrenal, renal function, (6) absence of diuretic use.
Urine osmolality (inappropriately concentrated, >100 mOsm/kg in true SIADH; usually >300)
Urine sodium (>30-40 mEq/L; reflects high renal Na excretion in euvolemic state)
TSH, AM cortisol (rule out hypothyroidism and adrenal insufficiency BEFORE diagnosing SIADH)
Uric acid (low <4 mg/dL in SIADH, high in volume depletion)
Random glucose, lipid panel (exclude pseudo/hypertonic hyponatremia)
Imaging
Chest CT — search for occult malignancy (small-cell lung cancer)
Head CT/MRI if neurologic symptoms or suspected intracranial cause
Other targeted imaging based on history
Diagnostic algorithm
flowchart TD
A["Hyponatremia<br/>(Na <135)"] --> B[Plasma osmolality]
B --> C{"Osm low <275?"}
C -->|"No (normal/high)"| D["Pseudo or hypertonic hyponatremia<br/>(glucose, mannitol, lipids)"]
C -->|"Yes (hypotonic)"| E[Volume status assessment]
E --> F{Hypovolemic?}
F -->|Yes| G[GI losses / diuretics / Addison<br/>Treat with normal saline]
F -->|Hypervolemic| H[CHF, cirrhosis, nephrotic<br/>Restrict water/Na, treat underlying]
F -->|Euvolemic| I[Urine osm + urine Na + uric acid]
I --> J{"Urine osm >100 + urine Na >30?"}
J -->|Yes| K["Exclude hypothyroid + adrenal insufficiency<br/>→ SIADH"]
J -->|"No (low urine osm)"| L[Primary polydipsia / beer potomania]
K --> M["Treat: water restrict 800 mL/day<br/>+ salt/urea load; vaptan if refractory<br/>Acute severe: 3% saline; limit Na rise to ≤8-10 mEq/L per 24 h"]
SIADH within the hyponatremia workup framework.
Complications
Acute: seizure, coma, brain herniation, death
Chronic mild: falls, fractures, gait/cognitive impairment
Always exclude HYPOTHYROIDISM and ADRENAL INSUFFICIENCY before diagnosing SIADH — these mimic and treat differently.
Uric acid is HIGH in volume depletion and LOW in SIADH — useful adjunct.
Cerebral salt wasting in the setting of CNS injury looks similar to SIADH but is HYPOVOLEMIC — treat with saline, NOT water restriction.
Correct slowly: ≤8-10 mEq/L in 24 h (6 in high-risk) to prevent ODS.
If you overshoot, re-lower with D5W ± DDAVP to bring sodium back to a safe trajectory.
Beer potomania and 'tea and toast' diet cause hyponatremia from low solute intake — treat with normal saline and food (solute) restoration.
References
European Society 2014 — Clinical Practice Guideline on Diagnosis and Treatment of Hyponatraemia (Spasovski et al., Eur J Endocrinol 2014 / Intensive Care Med 2014)
U.S. Expert Panel 2013 — Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations (Verbalis et al., Am J Med 2013)
Schwartz-Bartter 1957 — Original description of SIADH (Schwartz et al., Am J Med 1957)
Practice Endocrinology questions on FirstPassPA
Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.